Snapshot

DOI:

Focused and accessible - a renewed EuroIntervention!

We hope your year has begun well and full of excitement! It certainly has for us at EuroIntervention where we’re still at the beginning of all the new graphic changes and scheduling we spoke about in the last issue. And here it is – the first of our new, leaner, and more timely Journals that you will be receiving every 2 weeks. What do you think? We’re interested in your reactions and comments, so don’t hesitate to contact us online.

And, as for this issue itself, here are the key topics you’ll find right now:

EuroIntervention state-of-the-art

In a state-of-the-art on coronary spasm and vasomotor dysfunction, Zachary S. Yaker, Claire E. Raphael and colleagues review the current understanding, pathophysiology and treatment approaches for this frequently underdiagnosed condition.

Transcatheter aortic valve replacement explant for failed balloon-expandable valves vs failed self-expanding valves

Is mortality in transcatheter aortic valve replacement (TAVR) explantation associated with the type of failed transcatheter heart valve? Syed Zaid, Gilbert H.L. Tang and colleagues compare the outcomes of balloon-expandable valves versus self-expanding valves TAVR explantation using the EXPLANT-TAVR registry. The authors evaluate endocarditis, paravalvular leakage, structural valve deterioration and patient-prosthesis mismatch as well as mortality associated with the explantation of each valve type.

Prolonged mechanical circulatory support in high-risk PCI

What happens when you put high-risk PCI patients on prolonged mechanical circulatory support? Sugi Min, Jeffrey W. Moses and colleagues discuss early recognition of high-risk PCI and how best to wean patients off mechanical circulatory support, including the use of right heart catheterisation.

Real-world management of aortic stenosis patients

In a unique study out of Denmark, Xi Wang, Ole De Backer and colleagues examine the confluence of guideline recommendations and Heart Team evaluations. Focusing on a region with nearly 3 million people where all aortic stenosis patients are channelled through one centre, the authors analyse the value of the Heart Team in this “real-world” practice setting.

Volume 20 Number 2
Jan 15, 2024
Volume 20 Number 2
View full issue

Suggested by Cory

Expert Review

10.4244/EIJ-D-25-00201 Oct 10, 2025
Drug-coated balloons for coronary bifurcation lesions
Fezzi S et al
free

Editorial

10.4244/EIJ-E-25-00040 Oct 6, 2025
Photon-counting computed tomography for stent assessment
Andreini D and Di Mario C
free

Editorial

10.4244/EIJ-E-25-00042 Oct 6, 2025
Seeing is believing
Daemen J and Sadowski K
free

Editorial

10.4244/EIJ-E-25-00044 Oct 6, 2025
Just tap it in... stent optimisation in TAVI
Mylotte D and Thaddeus Soh B
free

Research Correspondence

10.4244/EIJ-D-25-00139 Oct 6, 2025
In-depth, patient-level analysis of clinical events in the NOTION-2 trial
Khokhar A et al

Flashlight

10.4244/EIJ-D-24-01165 Oct 6, 2025
Transcatheter tricuspid valve-in-ring following bicaval valve degeneration
Asmarats L et al

Original Research

10.4244/EIJ-D-25-00307 Oct 6, 2025
Impact of clinical risk characteristics on the prognostic value of high-risk plaques
Volleberg R et al
Trending articles
318.8

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
108.3

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
96.55

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
91.6

Image – Interventional flashlight

10.4244/EIJ-D-22-00344 Aug 5, 2022
First dedicated transcatheter leaflet splitting device: the ShortCut device
Tchétché D et al
free
67.55

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
56.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
56.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved